The CRI 2024 Spanish-Language Immunotherapy Summit is Available Online

CRI is proud to continue its commitment to the U.S. Hispanic and Spanish-speaking cancer community with on-demand free access to the 2024 CRI Spanish-Language Virtual Immunotherapy Patient Summit. Moderated by TV Host and Entrepreneur Ana Patricia Gámez, the summit is entirely free to the public. The Spanish-language summit can serve to connect Spanish-speaking cancer patients and caregivers with leading immunotherapy experts who are helping propel scientific progress against various cancers. Additionally, it is a great opportunity to learn about some of the current, innovative research that is improving the cancer immunotherapy space for patients, their families, and caregivers. 

Want to do something big for cancer immunotherapy research? Make a donation today to the Cancer Research Institute. 

The Spanish-language summit features several immunotherapy experts, including: 

• Eduardo Sotomayor, MD, VP and executive director of the Cancer Institute at Tampa General Hospital. 
• Dr Narjust Florez, MD, Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center; Associate Director, Cancer Care Equity Program; and member of the faculty at Harvard Medical School. 
• Jorge Marcet, MD, founder, Tampa General Hospital Cancer Institute; Director, Division of Colon and Rectal Surgery; and Professor, Morsani College of Medicine. 
• Manuel Hidalgo, MD, PhD, Professor of Medicine; Walter B. Wriston Professor of Pancreatic Cancer Research; Chief, Division of Hematology and Medical Oncology, Joan and Sanford I. Weill Department of Medicine; Associate Director for Clinical Services, Sandra and Edward Meyer Cancer Center. 
• Ivy Lorena Riano Monsalve, MD, faculty at the Dartmouth Geisel School of Medicine. 

According to the Centers for Disease Control and Prevention (CDC), cancer is the leading causes of death among Hispanic or Latino people in the U.S. Sobering statistics such as the fact that Hispanic women are at a greater risk for cervical cancer, or how Hispanic people have very high rates of contracting stomach cancer should alert the scientific and medical community that it needs to apply more focus to high-risk populations and lower barriers to equitable care. 

 The 2024 Spanish-Language Virtual Immunotherapy Patient Summit would not have been made possible without our partners: 

Sponsors: 

• Merck 
• Arthrex 
• Genmab 
• Regeneron 
• Lilly Oncology 
• Foundation Medicine 
• Pfizer Inc 

Host Institutions 

• Dana-Farber Cancer Institute 
• Dartmouth Cancer Center 
• Tampa General Hospital Cancer Institute 

• Weill Cornell Medicine Medical College